An Overview
To fulfill its mission, SPDS has been hosting annual conferences focused on dissolution science under the banner DISSO India. In 2020, for the first time, the event was conducted online due to the pandemic, featuring plenary lectures delivered by global experts. The remarkable success of DISSO India 2020 paved the way for DISSO America 2020 Online, organized by the SPDS US chapter in collaboration with the American Association of Pharmaceutical Scientists (AAPS).
Since research presentations could not be accommodated within DISSO India, SPDS launched a dedicated program titled Dissolution Research Presentations India 2020 – Online (DRPI 2020 – Online). This premier nationwide competition provided young researchers from both academia and industry with a platform to present innovative work in dissolution science, technology, and applications. Notably, it was the first indigenous online research competition for the pharmaceutical community, strengthened by SPDS’s partnership with the Association of Pharmaceutical Teachers of India (APTI). The contest was conducted across India’s five zones—North, East, West, South, and Central—and distinguished itself through a fair, fully anonymous evaluation process. Building on this success, DRPI continued online in 2021 and 2022, with SPDS collaborating again with APTI and AAPS to replicate the achievement.
Today, DRPI has evolved into Dissolution Research Presentations International. Since 2023, the competition has expanded globally.
The Competition
DRPI is a Global Dissolution Research Presentations Competition for Young (Early stage) Pharmaceutical Researchers.
Abstracts are accepted from 5 regions:
- India
- Rest of Asia
- Americas
- Europe
- Australia – New Zealand
under 2 categories:
- Category 1: For students enrolled in the Pharm.D., M.Pharm, M.S., MSc or M.Tech program (or graduated within the last six months).
- Category 2: For individuals pursuing Ph.D., Post Doctoral Trainees, and Industry Professionals. This category includes Ph.D.(s) who graduated within the last six months and Post Docs who left trainee-ship within the last six months.
focused on the following themes:
- Dissolution & Solubility Modulation
- In vitro Release/Permeation Studies of Conventional & Novel Dosage Forms, including Herbals, Nutraceuticals & Cosmeceuticals
- Development of newer Release testing methods, Modified Dissolution Equipment & Methodologies, including Biomimetic membranes, Biorelevant Media & Automation
- Research using Computational Tools, PBPK Modelling
- Pharmacokinetics & IVIVC Studies
DRPI - World Final Awards
Top 3 winners of DRPI-World Finals receive cash award as given below under both the categories, Masters and PhD.
Please Note: The participant will be eligible for only one cash prize, whichever is higher under each category.
1st Runner-up
Cash award of
USD 1500
2nd Runner-up
Cash award of
USD 1000
1st Prize
Cash award of
USD 2000
Upcoming DRPI Events & Announcements
The abstract submission window for DRPI – India 2026 is now open!
CLICK HERE TO SUBMIT YOUR ABSTRACT
Last date for abstract submission: July 26th, 2026
WINNERS of DRPI-World 2025
PhD | Post Doc | Industry : September 21, 2025
Michelle Cousineau
Purdue University, Indiana
Topic: Investigating Failure Mechanisms of Amorphous Solid Dispersions Using Multi-Modal Imaging Techniques.
Guide/Supervisor: Prof Lynne Taylor
Emily Benson
Purdue University, Indiana
Topic: Using Hypromellose Acetate Succinate (HPMCAS) Sodium Salts to Investigate the Release Mechanism of HPMCAS-based Amorphous Solid Dispersions.
Guide/Supervisor: Prof Lynne Taylor
Apurva Dusane
University of Iowa, Iowa
Topic: Topical liposomes for the treatment of Fuchs Endothelial Corneal Dystrophy (FECD) obviating the need for surgery.
Guide/Supervisor: Dr Aliasger Salem
M Pharm | Pharm D | Masters : September 20, 2025
Namish Manchanda
NIPER, SAS Nagar, India
Topic: Unveiling the Potential of Hydrophobic Ion-pair-loaded Self-Nanoemulsifying Drug Delivery System in Enhancing the Oral Bioavailability of Doxorubicin.
Guide/Supervisor: Prof. Dr. Sanyog Jain
Anisha Herala
NIPER, Guwahati, India
Topic: Unveiling Tunable ‘Ghost’ to ‘Non-Ghost’ Matrix Transition and Drug Release Using DLP-3D Printing with Green Bio-Ionic Liquid (BIL) Resins.
Guide/Supervisor: Prof. Dr. Subham Banerjee
Azica Kurnia Nirwana
Bandung Institute of Technology, Indonesia
Topic: Microencapsulation Study of PLGA-Based Leuprolide Acetate for Sustained-Release Drug Delivery and In Vitro Characterization.
Guide/Supervisor: Prof. Heni Rachmawati
WINNERS of DRPI-World 2024
PhD | Post Doc | Industry : September 21, 2024
Coleman Johnson
University of Texas, Austin, USA
Topic:Investigation of Biopredictive Dissolution Testing and In-Vitro-In-Vivo Correlations (IVIVCs) for Dexamethasone Intravitreal Implants in Rabbits.
Guide/Supervisor: Dr Feng Zhang
Stefanie Broocks
University of Greifswald, Germany
Topic: One like the other? - Development of a Novel In-vitro Release Method to Assess Drug Release of Extended-Release Mini-Tablets for Pediatric use
.
Guide/Supervisor: Prof Sandra Klein
Giorgia Frigerio
University of Bath, UK
Topic:Insight into SubQ In-Vitro Release Testing for PLGA Microspheres.
Guide/Supervisor: Prof Nikoletta Fotaki
WINNERS of DRPI-World 2023
PhD | Post Doc | Industry : September 23, 2023
Niloufar Salehi
Eli Lilly & Company, Indianapolis
Topic:Comparative evaluation of dissolution performance in USP 2 setup and alternative stirrers and vessel designs: A systematic computational investigation.
Guide/Supervisor: Prof Gregory Amidon
Pooja Todke
Institute of Chemical Technology, Mumbai
Topic: Amphotericin B Nanoformulation Insta-AmB - Tracking Safer Monomeric AmB release.
Guide/Supervisor: Prof Padma Devarajan
Sushesh Srivatsa Palakurthi
Texas A&M University, Kingsville, TX
Topic:Development and Validation of Microdialysis-Based Discriminatory and Biorelevant In vitro Release Testing Instrument for Complex Ophthalmic Products.
Guide/Supervisor: Prof Srinath Palakurthi
M Pharm | Pharm D | Masters : September 24, 2023
Asseel Alregib
Taylor’s University, Selangor, Malaysia,
Topic: Drug release from a biodegradable Chemo-Radioembolization agent loaded with SM-153 Radionuclide and Doxorubicin.
Guide/Supervisor: Prof Chai Hong Yeong
Dharshini M
NIPER, SAS Nagar, India
Topic: Supersaturable Bio-Self-Nanoemulsifying Drug Delivery System for Improving Oral Bioavailability of Dasatinib.
Guide/Supervisor: Prof Sanyog Jain
Bharathi K
NIPER, Ahmedabad, India
Topic: Formulation development and in-vitro characterization of hot-melt extruded cyclosporine ocular inserts for dry eye disease.
Guide/Supervisor: Dr Derajram Benival